Some cells from cultured embryonic mouse hypothalamus were found to express aromatic-L-amino acid decarboxylase (EC 4.1.1.28) activity and serotonin uptake and storage. These neuron-like cells differed from serotoninergic neurons in cultured embryonic mouse brain stem since they did not contain tryptophan hydroxylase. We studied the effect of the serotonin agonist 8-hydroxy-2-[di-(n-propyl)amino]tetralin on neuronal differentiation of hypothalamic cells from 12-to 15-day embryos. Repeated treatment of cultures with the serotonin agonist for 10 days resulted in an increased number of serotonin cells containing high levels of decarboxylase activity. Both the increase in cell numbers and the elevated decarboxylase activity could be suppressed by the addition of the serotonin antagonist metergoline to the culture medium. These data show that serotonin (or an agonist), acting on specific receptors, can initiate and amplify its own synthesis in embryonic hypothalamic neurons, as observed in the primitive hypothalamic nerve cell line F7
the serotonin agonist 8-hydroxy-2-[di-(n-propyl)amino]tetralin on neuronal differentiation of hypothalamic cells from 12-to 15-day embryos. Repeated treatment of cultures with the serotonin agonist for 10 days resulted in an increased number of serotonin cells containing high levels of decarboxylase activity. Both the increase in cell numbers and the elevated decarboxylase activity could be suppressed by the addition of the serotonin antagonist metergoline to the culture medium. These data show that serotonin (or an agonist), acting on specific receptors, can initiate and amplify its own synthesis in embryonic hypothalamic neurons, as observed in the primitive hypothalamic nerve During embryogenesis, an ordered sequence of genetically programmed cellular commitments progressively orchestrates the development of a multipotent egg into a complex organism. The expression of the genetic program, however, relies on the availability, in time and space, of adequate environmental epigenetic factors. Their combined action ensures initiation, amplification, and stabilization of each differentiated state. Thus one may predict a cascade of differentiation episodes, each depending upon repetitive external stimuli and driving developmental progression of the embryo to the adult. The purpose of our investigations was to explore whether such differentiation processes could also be achieved in cell culture.
In the central nervous system, neuronal and glial lineages originate from a common precursor, whose time of appearance is still debated (1, 2) . If repetitive external stimuli are necessary for the differentiation of neuronal or glial precursor cells into specific types of neurons or glial cells, it should be possible to mimic this mechanism in vitro. Initially we used the pluripotent embryonic hypothalamic nerve cell line F7 to initiate distinct neuronal or glial functions by establishing appropriate external signals in the culture environment (3, 4). Thus, it was possible to induce serotonin (5-hydroxytryptamine or 5-HT) synthesis from 5-hydroxytryptophan, L-form, (5-HTP) by repetitive treatment ofthe F7 cell line with a 5-HT agonist and eye-derived growth factor in appropriate culture conditions (4) . In this particular case, an autocrine-like mechanism seemed to be involved in nerve cell differentiation.
In brain, serotoninergic neurons are characterized by their ability to convert tryptophan into 5-HT via two successive enzymatic steps catalyzed by tryptophan hydroxylase and aromatic-L-amino acid decarboxylase (AA decarboxylase; EC 4.1.1.28) (5) . These neurons are mainly located within the raphe nuclei at the brain stem level (6), but 5-HT-containing cell bodies can be visualized also in the hypothalamus after an intraventricular perfusion of 5-HT (7, 8) or of 5-HTP (9) . This led us to select these two regions from fetal mouse brain as sources of neurons and examine the possible effect of the potent 5-HT agonist 8-hydroxy-2-[di(n-propyl)amino]tetralin (8-OH-DPAT) (10) added to their culture medium upon the nerve cell capacity to synthesize and take up 5-HT. The present data provide experimental support for a stimulatory effect of 5-HT, via autocrine or paracrine-like mechanisms, on the expression of specific biochemical markers in serotoninergic neurons.
MATERIALS AND METHODS
Cell Cultures. The method described (11) was used, except that hypothalamic and brain stem cells were cultured on dishes coated with protamine (10 ,g/ml of Ham's F12 medium for 1-2 hr at 37°C). The 5-HT agonist 8-OH-DPAT (10 nM) was added to the cultures on days 4, 7, and 9. Where indicated, 1 ,M metergoline was added 30 min before each 8-OH-DPAT treatment.
Antisera. Antibodies to formaldehyde-linked 5-HT-bovine serum albumin conjugates were raised in rabbits and purified as described (12) . The 5-HT antiserum presently used exhibited no crossreactivity with 5-HTP, 8-OH-DPAT, dopamine, norepinephrine, or numerous other related molecules (4, 12) . Before use, the 5-HT antiserum was preadsorbed for 1 day with 0.2% bovine serum albumin. The characteristics of the antiserum obtained in rabbits immunized with tyrosine hydroxylase purified from rat pheochromocytoma have been described in detail elsewhere (13) . Antiserum to glial fibrillary acidic protein was from DAKO (Santa Barbara, CA).
Antibodies to -y-enolase (EC 4.2.1.11) were a generous gift from L. Legault (College de France, Paris).
Immunocytochemical Techniques. Identification of serotoninergic neuron-like cells. For brain stem cultures, 5-HT immunoreactivity was detected using the immunoperoxidase technique as described (4) . In the case of hypothalamic cultures, cells were first treated with 1 ,uM 5-HTP for 2 hr at 37°C, then fixed and assayed for 5-HT immunoreactivity. 
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Identification of other cell types present in cultures. The presence of astrocytes was assessed in cultures fixed with ethanol/10% (vol/vol) formaldehyde (9:1, vol/vol) at 4TC for 10 min, by indirect immunohistochemistry using a glial fibrillary acidic protein antiserum. Cells with neuronal morphology were identified as neuronal cells using an antiserum against -y-enolase, at a final dilution of 1:1000.
Detection of tryptophan hydroxylase activity. Cells were cultured in the presence or absence ofp-chlorophenylalanine (1 mM, added on days 4, 7, and 9), a specific inhibitor of tryptophan hydroxylase (5) , and then exposed to the monoamine oxidase inhibitor pargyline (10 AiM, ref. 5) on day 10, 2 hr before fixation. 5-HT immunoreactivity was assessed as above.
Detection of AA decarboxylase activity. Cells were cultured in the presence or absence of carbidopa (20 ,M, added on days 4, 7, and 9), a specific inhibitor of AA decarboxylase (5), and incubated on day 10 with 1 ,uM 5-HTP and 10 AM pargyline for 2 hr before fixation. Cells were then processed for 5-HT immunoreactivity.
Detection ofS-HT storage. Cells were treated with 1 ,uM 5-HTP on days 4 and 7 and processed for 5-HT immunoreactivity on day 10.
Uptake of 3H-Labeled 5-HT. Cultures were treated for 30 min with 10 ,M pargyline, and then exposed to 3H-labeled 5 (Fig. 2) , representing 1.5-2.5% of total neurons present, as assessed by -y-enolase immunoreactivity. 5-HT-immunoreactive cells had big soma as compared to other hypothalamic neurons and were often fusiform with bipolar processes or pyramidal with tripolar processes (Fig. 1) . The accumulation of 5-HT newly synthesized from 5-HTP was observed only when its catabolism was inhibited by pargyline. In contrast brain stem embryonic serotoninergic neurons exhibited 5-HT immunoreactivity, even in the absence of 5-HTP and pargyline ( occasionally with short processes, were among these recruited immunoreactive cells ( Fig. 1 b and c) . As already mentioned for hypothalamic neuronal cells cultivated in the absence of 8-OH-DPAT (Fig. la) , the 5-HT immunoreactivity directly resulted from the activity of AA decarboxylase within cells, since no immunostaining was found when the medium containing 8-OH-DPAT was supplemented with 20 ,M carbidopa. Direct biochemical measurement of 5-HTP decarboxylation in cultures exposed to 8-OH-DPAT (as that performed with the primitive nerve cell line F7, ref. 4) was not possible as the substrate 3H-labeled 5-HTP is no longer available from any commercial source. Nevertheless, immunocytochemical data were highly reproducible using cultures from ED 14 embryos, and the same developmental stage was chosen for further characterization of the possible effects of 8-OH-DPAT upon 5-HT uptake and accumulation in hypothalamic cells.
In these serum-containing cultures, some nonneuronal cells exhibited glial fibrillary acid protein immunoreactivity. The bodies and processes of cells with typical neuronal morphology were almost invariably stained using a y-enolase antiserum. Most flat cells underlying neurons exhibited neither -y-enolase nor glial fibrillary acid protein immunoreactivity.
Evidence (Fig. 4 a and  c) , but in some instances only long processes and occasionally growth cones were labeled. These few labeled neuronallike cells were found as early as ED 12, indicating that 3H-labeled 5-HT uptake and AA decarboxylase appeared simultaneously (Fig. 2) . In cultured cells from embryonic hypothalamus or brain stem, 3H-labeled 5-HT uptake was abolished in the presence of citalopram, a specific blocker of 5-HT uptake, but was unaffected by nomifensine, a specific blocker of dopamine and norepinephrine uptake. These results showed that uptake capacity of hypothalamic 5-HT neuronal-like cells was pharmacologically identical with that of typical serotoninergic neurons and distinct from that of catecholaminergic cells.
As shown in Fig. 3 , intracellular storage of 
DISCUSSION
This study revealed that neuron-like cells from embryonic hypothalamus, from ED 12 and on, express some of the characteristics typical of serotoninergic neurons: AA decarboxylase activity and 5-HT uptake and storage are present in the same neuron-like cells, which also express the -y-enolase antigen, a specific marker of neuronal cells in these cultures. However, such neuron-like cells containing 5-HT differ from brain stem embryonic serotoninergic neurons ( Fig. 1 ; see also ref. 14), since they lack the specific enzyme tryptophan hydroxylase. They differ also from catecholaminergic embryonic neurons since they lack tyrosine hydroxylase, as revealed by immunocytochemistry using tyrosine hydroxylase antiserum. Cells able to accumulate exogenous 5-HTP or 3H-labeled 5-HT have been visualized in the hypothalamus of adult rats (7) (8) (9) , but the simultaneous presence of AA decarboxylase activity and 5-HT uptake in the same cells is poorly documented. Cells containing immunoreactive AA decarboxylase have already been visualized early in development in the mesencephalon (15) . In the present study, the use of an appropriate double labeling technique allows us to conclude that AA decarboxylase catalyzing the conversion of 5-HTP into 5-HT, and 3H-labeled 5-HT uptake are actually present within the same hypothalamic neuron-like cells.
It has been suggested that monoamines can play a neurotrophic role in early ontogenesis (16, 17) , probably via the stimulation of specific receptors on target cells (17) . In the present study, the involvement of specific 5-HT receptors on neuron-like cells can be proposed on account of the effects of the potent 5-HT agonist 8-OH-DPAT and their blockade by the 5-HT antagonist metergoline (5). The 8-OH-DPATinduced increase in the number of 5-HT neuron-like cells probably did not result from a better survival of neurons, as assessed by direct counting of cells in control and 8-OH-DPAT-treated cultures. Furthermore, cell attachment was not affected by the addition of 10 nM 8-OH-DPAT to the culture medium 24 hr after cell seeding (unpublished observations). Therefore, these data provide evidence that the 5-HT agonist 8-OH-DPAT could act by stimulating the synthesizing capacity of cells already committed-at least partially-to the serotoninergic phenotype. Such autocrine or paracrine-like mechanisms for self-stimulation may be of critical importance during early development of the nervous system.
These results also support and extend the conclusion of our studies (4) that showed that under appropriate culture conditions, repetitive treatment with a 5-HT agonist and eyederived growth factor, irreversibly induced AA decarboxylase activity in the primitive hypothalamic cell line F7: such induction, reinforcement, and stabilization of the commitment of one cell have been defined as a "learning" process at the cellular level (4) . The capacity of embryonic nerve cells to synthesize and respond to their own neurotransmitter, and the stimulatory effect of a neurotransmitter, such as 5-HT, on the neuron commitment to a given neurochemical specificity, could be an important concept in determining the functional link between neurotransmitters and brain development.
